As most clinicians are well aware, intracranial hemorrhage (ICH) is a serious complication associated with significant mortality and long-term neurological morbidity, making it essential to understand ...

Direct oral anticoagulant (DOAC) therapy is not associated with a significantly higher risk for intracranial hemorrhage than single-agent antiplatelet therapy. However, DOACs are linked to an ...

Rising vitamin K refusal rates correlated with later healthcare hesitancy, including higher likelihoods of refusing childhood immunizations.

When ICH occurs, small, deep-penetrating arteries rupture, causing bleeding into the brain parenchyma. Bleeding can occur in the cerebral hemispheres, basal ganglia, brainstem, cerebellum, or the ...

Results from a new meta-analysis provide yet more support against the routine use of aspirin for the primary prevention of atherosclerotic cardiovascular disease (ASCVD). Low-dose aspirin use in ...

With a slew of FDA nods this year alone, artificial intelligence can now be widely used in hospital settings to quickly detect the presence of bleeding within the skull or brain. But a new AI tool is ...

Dr. Frank Brodkey shares key insights from andexanet's development, approval, and real-world clinical trajectory.

Similar risks seen for apixaban and dabigatran vs aspirin, while rates were higher for rivaroxaban. HealthDay News — Rates of major bleeding and intracranial hemorrhage are similar for apixaban and ...

Low-dose aspirin is linked to an increased risk of bleeding in the skull among people who do not have heart disease, according to a new study Rachel DeSantis is a senior writer on the music team at ...